Cost-Effectiveness of Canagliflozin (Cana) Versus Sitagliptin (Sita) As Add-On To Metformin Plus Sulfonylurea In Patients With Type 2 Diabetes Mellitus (T2dm) In Brazil
Nov 1, 2015, 00:00
10.1016/j.jval.2015.09.510
https://www.valueinhealthjournal.com/article/S1098-3015(15)02586-3/fulltext
Title :
Cost-Effectiveness of Canagliflozin (Cana) Versus Sitagliptin (Sita) As Add-On To Metformin Plus Sulfonylurea In Patients With Type 2 Diabetes Mellitus (T2dm) In Brazil
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(15)02586-3&doi=10.1016/j.jval.2015.09.510
First page :
A864
Section Title :
Research Podium Presentations - Session 1
Open access? :
No
Section Order :
2729